ProMetic regains majority control of NantPro - ProMetic Life - TopicsExpress



          

ProMetic regains majority control of NantPro - ProMetic Life Sciences (TSE:PLI)(OTCQX:PFSCF) has boosted its interest in NantPro, regaining its majority equity stake and board control in the company whose chief program is targeting the $4 billion intravenous immunoglobulin (IVIG) U.S. market. ProMetic is planning to drive the IVIG development programs, and said that as a result of the deal, it will receive a greater portion of the future value and revenues associated w... ow.ly/2GwHde
Posted on: Fri, 09 May 2014 18:34:40 +0000

Trending Topics



Recently Viewed Topics




© 2015